11/07/2002
London, UK – 11 July, 2002: ReGen Therapeutics Plc (the ‘Company’) announces that on 10 July 2002 it received notification from Mr P. Garrod that he is beneficially interested in 2,679,500 ordinary shares of the Company representing 3.73% of the current issued share capital of the Company.
For further information, please contact:
Lisa Baderoon
BUCHANAN COMMUNICATIONS
Tel. 020 7466 5000
lisab@buchanan.uk.com